Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 24 (3) , 396-411
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?BMC Cancer, 2010
- The MLH1 −93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancerGenes, Chromosomes and Cancer, 2008
- DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinomaBritish Journal of Cancer, 2008
- The CpG Island Methylator Phenotype Correlates with Long-Range Epigenetic Silencing in Colorectal CancerMolecular Cancer Research, 2008
- Evaluation of Markers for CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer by a Large Population-Based SampleThe Journal of Molecular Diagnostics, 2007
- Colorectal cancer: a model for epigenetic tumorigenesisGut, 2006
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Precision and Performance Characteristics of Bisulfite Conversion and Real-Time PCR (MethyLight) for Quantitative DNA Methylation AnalysisThe Journal of Molecular Diagnostics, 2006
- BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non‐mucinous colorectal cancerInternational Journal of Cancer, 2006
- Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomasOncogene, 2004